Abstract
Background: The emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in early 2020 and subsequent implementation of public health and social measures (PHSM) disrupted the epidemiology of respiratory viruses. This work describes the epidemiology of respiratory syncytial virus (RSV) observed during two winter seasons (weeks 40–20) and inter-seasonal periods (weeks 21–39) during the pandemic between October 2020 and September 2022. Methods: Using data submitted to The European Surveillance System (TESSy) by countries or territories in the World Health Organization (WHO) European Region between weeks 40/2020 and 39/2022, we aggregated country-specific weekly RSV counts of sentinel, non-sentinel and Severe Acute Respiratory Infection (SARI) surveillance specimens and calculated percentage positivity. Results for both 2020/21 and 2021/22 seasons and inter-seasons were compared with pre-pandemic 2016/17 to 2019/20 seasons and inter-seasons. Results: Although more specimens were tested than in pre-COVID-19 pandemic seasons, very few RSV detections were reported during the 2020/21 season in all surveillance systems. During the 2021 inter-season, a gradual increase in detections was observed in all systems. In 2021/22, all systems saw early peaks of RSV infection, and during the 2022 inter-seasonal period, patterns of detections were closer to those seen before the COVID-19 pandemic. Conclusion: RSV surveillance continued throughout the COVID-19 pandemic, with an initial reduction in transmission, followed by very high and out-of-season RSV circulation (summer 2021) and then an early start of the 2021/22 season. As of the 2022/23 season, RSV circulation had not yet normalised.
Original language | English |
---|---|
Article number | e13219 |
Journal | Influenza and other Respiratory Viruses |
Volume | 17 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2023 |
Externally published | Yes |
Funding
Funders | Funder number |
---|---|
Anne Teirlinck | |
CHU Saint-Pierre | |
CIBERESP | |
Consejería de Sanidad, Castilla y León | |
Department of Epidemiology | |
Department of Hygiene, Epidemiology and Prevention | |
Department of Infectious Diseases | |
Department of Microbiology and Infection control | |
Department of Microbiology, Jessa Ziekenhuis | |
Dr Sultan Djemileva | |
Dutch Society for Clinical Microbiology | |
Dutch Working Group on Clinical Virology | |
Eliisa Metsoja | |
Estonian Health Board Influenza Centre | |
Hai Xi Wiegmans | |
Inmaculada Casas | |
Laboratory Network for Influenza | |
Liisa Lilje | |
NWKV | |
National Center of Epidemiology | |
National Center of Microbiology | |
National Institute of Health Doctor Ricardo Jorge | |
National Institute of Public Health of Kosovo | |
Public Health Wales Virology | |
Sanitary and Epidemiological Welfare and Public Health Service of the Republic of Uzbekistan | |
Service of Clinical Biology | |
Swiss Sentinel Network | |
United Nations Security Council | |
National Institutes of Health | |
Ministry of Health | |
Department of Pediatrics, School of Medicine, University of Virginia | |
European Centre for Disease Prevention and Control | |
Bundesamt für Gesundheit | |
Rijksinstituut voor Volksgezondheid en Milieu | |
Université libre de Bruxelles | |
Nederlandse Vereniging voor Medische Microbiologie | |
Innovative Medicines Initiative | |
Centre hospitalier universitaire Sainte-Justine |
Keywords
- COVID-19 pandemic
- Europe
- epidemiology
- respiratory syncytial virus
- severity
- surveillance